Skye Bioscience Inc.

06/30/2022 | Press release | Distributed by Public on 06/30/2022 05:11

Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion